CARDIOSTIM 2010
June 16-19, 2010
Nice Acropolis - French Riviera
17th World Congress
in Cardiac Electrophysiology & Cardiac Techniques
Home /
Press Corner /
live EP information
Cardiostim is glad to present the last information on EP and Arrhythmia updated every day from our partner The Heart.org.
| View all heartwire news >> |
|
Vernakalant cleared in EU for conversion of AF to sinus rhythm |
A novel intravenous drug, vernakalant, has been approved in the European Union, Iceland, and Norway for the rapid conversion of recent-onset atrial fibrillation to sinus rhythm in adults. |
|
|
STS registry data on bypass surgery published for consumers |
Risk-adjusted coronary bypass surgery outcomes data from one-fifth of US heart-surgery programs is now available to the public. |
|
|
First Europe-specific guidance on AF |
The European Society of Cardiology announced new clinical guidelines for atrial fibrillation at its congress in Stockholm last week, the first time such recommendations have been prepared by European societies acting alone. Highlights include guidance on the use of dronedarone, better risk profiling for stroke in anticipation of new oral anticoagulants, the formal acceptance of ablation as a treatment option, and the recognition that lenient rate control is a satisfactory alternative to strict control. |
|
|
ESC guidelines give top recommendation to CRT for mild heart failure |
It's been in the wind on both sides of the Atlantic; now it's official in Europe: a class I A recommendation for cardiac resynchronization therapy for patients in sinus rhythm with NYHA class 2 systolic heart failure with a QRS duration >150 ms. |
|
|
REALISE-AF registry: Much still to do in atrial fibrillation |
Preliminary data from a new registry of more than 10 000 patients with AF, the largest ever, spanning 26 countries, shows that that much remains to be done in this field. AF is frequently not controlled, and even when it is, patients are often symptomatic. In addition, physicians need better guidance on how to treat AF, and better drug and devices are required, say experts. |
|
|
Charity Run

